← Back to Search

light-scattering spectroscopy for Breast Cancer

N/A
Waitlist Available
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial is using optical spectroscopy to see how well it works in evaluating tumor margins in patients who have undergone surgery for breast cancer.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Development of a non-invasive detection tool that evaluates breast tumor margins in real-time to guide tumor resection during partial mastectomy procedures
Evaluated optical spectroscopy in differentiating breast tumor or tumor margins from normal breast tissue

Trial Design

1Treatment groups
Experimental Treatment
Group I: Optical spectroscopy on tumor marginsExperimental Treatment4 Interventions
Optical spectroscopy is performed on breast tumor margins obtained from patients undergoing surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
breast biopsy
2006
N/A
~110
light-scattering spectroscopy
2006
N/A
~110
therapeutic conventional surgery
2003
Completed Phase 3
~12270
histopathologic examination
2003
Completed Phase 2
~170

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor
707 Previous Clinical Trials
6,143,431 Total Patients Enrolled
11 Trials studying Breast Cancer
1,430 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,748 Previous Clinical Trials
40,959,299 Total Patients Enrolled
943 Trials studying Breast Cancer
1,543,906 Patients Enrolled for Breast Cancer
Anita Mahadevan-Jansen, MDStudy Chair - Vanderbilt-Ingram Cancer Center
Vanderbilt University
~5 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top